VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Anthropometric proxies for child neurodevelopment in low-resource settings: length- or height-for-age, head circumference or both?
Cell cycle inhibitors for the treatment of acute myeloid leukemia: a review of phase 2 & 3 clinical trials.
Enhanced Immunotherapy with LHRH-R Targeted Lytic Peptide in Ovarian Cancer.
Pharmacokinetics of posaconazole prophylaxis of patients with acute myeloid leukemia
Polyglutamine disease toxicity is regulated by Nemo-like kinase in spinocerebellar ataxia type 1.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Polyglutamine disease toxicity is regulated by Nemo-like kinase in spinocerebellar ataxia type 1.
Polyglutamine disease toxicity is regulated by Nemo-like kinase in spinocerebellar ataxia type 1. J Neurosci. 2013 May 29; 33(22):9328-36.
View in:
PubMed
subject areas
Animals
Animals, Genetically Modified
Ataxin-1
Ataxins
Behavior, Animal
Blotting, Western
Brain
Cerebellum
Chromatography, Gel
Drosophila melanogaster
Female
Gene Expression
HEK293 Cells
Heredodegenerative Disorders, Nervous System
Humans
Immunoprecipitation
Mice
Mice, Inbred C57BL
Mice, Transgenic
Mitogen-Activated Protein Kinases
Nerve Tissue Proteins
Nuclear Proteins
Peptides
Phosphorylation
Spinocerebellar Ataxias
authors with profiles
HUDA ZOGHBI